New LightSpy spyware variant comes with enhanced data collection features targeting social media platforms

Critical insights Q&A: Anomali’s AI-native approach helps defenders cut noise, mitigate swiftly

The cybersecurity world is deep into an AI pivot. Related: The case for AI-native SOCs The headlines fixate on doomsday threats and autonomous cyber weapons.

BioCryst’s 0M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE

BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE

BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential

Are Your Cloud Identities Fully Protected?

How Can We Bridge the Gap Between Security and R&D Teams for Effective Cloud Identity Protection? Where organizations across various sectors increasingly rely on cloud

Innovating Identity and Access Management

How Can Non-Human Identities Revolutionize Cybersecurity in Cloud Environments? Securing digital identity and access management (IAM) is crucial for organizations that operate in cloud environments.

News and Analysis

Subscribe to newsletter

More Posts

Critical insights Q&A: Anomali’s AI-native approach helps defenders cut noise, mitigate swiftly

BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE

Are Your Cloud Identities Fully Protected?

Innovating Identity and Access Management

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company